David Crowe

591 total citations
33 papers, 389 citations indexed

About

David Crowe is a scholar working on Molecular Biology, Organic Chemistry and Genetics. According to data from OpenAlex, David Crowe has authored 33 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Organic Chemistry and 6 papers in Genetics. Recurrent topics in David Crowe's work include Steroid Chemistry and Biochemistry (11 papers), Estrogen and related hormone effects (6 papers) and Organic Chemistry Cycloaddition Reactions (6 papers). David Crowe is often cited by papers focused on Steroid Chemistry and Biochemistry (11 papers), Estrogen and related hormone effects (6 papers) and Organic Chemistry Cycloaddition Reactions (6 papers). David Crowe collaborates with scholars based in United States, United Kingdom and Sweden. David Crowe's co-authors include Masato Tanabe, Ralph J. Fessenden, Wesley K. M. Chong, George Detre, Mitchell A. Avery, Mitchell A. Avery, Dennis Yasuda, Michael J. Osborne, Elliot L. Shapiro and Alan K. Mallams and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biochemical Journal.

In The Last Decade

David Crowe

31 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Crowe United States 11 238 142 49 46 30 33 389
Helmut Hofmeister Australia 10 322 1.4× 134 0.9× 34 0.7× 59 1.3× 38 1.3× 29 432
Mitsuo Nagai Japan 14 319 1.3× 217 1.5× 47 1.0× 68 1.5× 28 0.9× 30 466
Forrest J. Frank United States 5 298 1.3× 130 0.9× 39 0.8× 13 0.3× 31 1.0× 7 413
A. R. Daniewski Poland 14 324 1.4× 153 1.1× 39 0.8× 24 0.5× 26 0.9× 36 431
John F. Poletto China 9 257 1.1× 124 0.9× 30 0.6× 21 0.5× 22 0.7× 22 342
Klaus Annen Australia 8 266 1.1× 84 0.6× 26 0.5× 30 0.7× 35 1.2× 24 337
Candido Gude United States 12 487 2.0× 196 1.4× 67 1.4× 82 1.8× 37 1.2× 24 670
Beverly A. Pawson United States 11 244 1.0× 125 0.9× 20 0.4× 21 0.5× 35 1.2× 23 387
J. Fajkoš Czechia 9 175 0.7× 225 1.6× 23 0.5× 66 1.4× 22 0.7× 109 389
J. M. Chemerda United States 12 175 0.7× 214 1.5× 26 0.5× 35 0.8× 20 0.7× 31 384

Countries citing papers authored by David Crowe

Since Specialization
Citations

This map shows the geographic impact of David Crowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Crowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Crowe more than expected).

Fields of papers citing papers by David Crowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Crowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Crowe. The network helps show where David Crowe may publish in the future.

Co-authorship network of co-authors of David Crowe

This figure shows the co-authorship network connecting the top 25 collaborators of David Crowe. A scholar is included among the top collaborators of David Crowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Crowe. David Crowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chahoud, Jad, Yousef Zakharia, Meredith McKean, et al.. (2024). Phase 1/2 study of XTX202, a tumor-activated IL-2βγ, in advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 2595–2595. 1 indexed citations
2.
Henry, Scott P., Cecilia Arfvidsson, David Crowe, et al.. (2022). Assessment of the Immunogenicity Potential for Oligonucleotide-Based Drugs. Nucleic Acid Therapeutics. 32(5). 369–377. 8 indexed citations
3.
Rickles, Richard J., Winnie F. Tam, Thomas P. Giordano, et al.. (2012). Adenosine A2A and Beta-2 Adrenergic Receptor Agonists: Novel Selective and Synergistic Multiple Myeloma Targets Discovered through Systematic Combination Screening. Molecular Cancer Therapeutics. 11(7). 1432–1442. 13 indexed citations
4.
Rickles, Richard J., Laura Pierce, Thomas P. Giordano, et al.. (2008). Adenosine A2A and Beta-2 Adrenergic Receptor Agonism: Novel Selective and Synergistic Multiple Myeloma Targets Discovered through Systematic Combination Screening. Blood. 112(11). 384–384. 1 indexed citations
5.
Osborne, Michael J., et al.. (2003). NMR of Paramagnetic Proteins. Humana Press eBooks. 60. 233–270. 2 indexed citations
6.
Moore, Geoffrey R., David Crowe, Michael J. Osborne, et al.. (1998). Nε,Nε-Dimethyl-lysine cytochrome c as an NMR probe for lysine involvement in protein–protein complex formation. Biochemical Journal. 332(2). 439–449. 19 indexed citations
7.
Avery, Mitchell A., et al.. (1990). Synthesis and antiinflammatory activity of novel 12.beta.-substituted analogs of betamethasone. Journal of Medicinal Chemistry. 33(7). 1852–1858. 10 indexed citations
8.
Avery, Mitchell A., et al.. (1990). Synthesis and testing of 17aβ-hydroxy-7α-methyl-d-homoestra-4, 16-dien-3-one: a highly potent orally active androgen. Steroids. 55(2). 59–64. 9 indexed citations
9.
Crowe, David, et al.. (1989). 17-Desoxy estrogen analogs. Journal of Medicinal Chemistry. 32(7). 1642–1652. 33 indexed citations
10.
Crowe, David, et al.. (1989). 11.beta.-Nitrate estrane analogs: potent estrogens. Journal of Medicinal Chemistry. 32(10). 2306–2310. 25 indexed citations
11.
Crowe, David, et al.. (1988). Analogs of [(triethylsilyl)ethynyl]estradiol as potential antifertility agents. Journal of Medicinal Chemistry. 31(3). 572–576. 7 indexed citations
12.
Tolf, Bo‐Ragnar, et al.. (1984). Synthesis of pentacyclic lα,11-(2-oxethano) steroids. Tetrahedron Letters. 25(43). 4855–4858. 4 indexed citations
13.
Crowe, David, et al.. (1983). Synthesis of multi carbon-13 labeled dexamethasone. Tetrahedron. 39(19). 3083–3090. 4 indexed citations
14.
Mallams, Alan K., et al.. (1976). Semisynthetic aminoglycoside antibacterials. Part V. Synthesis of pentosyl and related derivatives of garamine. Journal of the Chemical Society Perkin Transactions 1. 1135–1135. 4 indexed citations
15.
Mallams, Alan K., et al.. (1973). THE SYNTHESIS OF 4"-DEOXYGENTAMICIN C1. The Journal of Antibiotics. 26(12). 782–783. 5 indexed citations
16.
Tanabe, Masato & David Crowe. (1969). A novel 11-enolate ion of a pregna-1,4-diene-3,11-dione from sodium bistrimethylsilylamide. Journal of the Chemical Society D Chemical Communications. 1498–1498. 5 indexed citations
17.
Tanabe, Masato & David Crowe. (1967). The synthesis of steroidal 1β,2β-methylene derivatives. Tetrahedron. 23(5). 2115–2121. 1 indexed citations
18.
Tanabe, Masato, et al.. (1967). A novel fragmentation reaction of α,β-epoxyketones the synthesis of acetylenic ketones. Tetrahedron Letters. 8(40). 3943–3946. 54 indexed citations
19.
Tanabe, Masato & David Crowe. (1965). The Synthesis of a 13,14-Seco Steroid Analog1. The Journal of Organic Chemistry. 30(8). 2776–2779. 11 indexed citations
20.
Shapiro, Elliot L., et al.. (1964). Deconjugation of Δ1,4 -3-ketosteroids. Steroids. 3(2). 183–188. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helmut Hofmeister Breakdown of academic impact, for papers by Mitsuo Nagai Breakdown of academic impact, for papers by Forrest J. Frank Breakdown of academic impact, for papers by A. R. Daniewski Breakdown of academic impact, for papers by John F. Poletto Breakdown of academic impact, for papers by Klaus Annen Breakdown of academic impact, for papers by Candido Gude Breakdown of academic impact, for papers by Beverly A. Pawson Breakdown of academic impact, for papers by J. Fajkoš Breakdown of academic impact, for papers by J. M. Chemerda
Rankless by CCL
2026